Understanding how the CDs relieve cholesterol accumulation in NPC mutant cells will contribute to the development of effective therapeutic approaches for neurodegenerative lipid storage disorders such as NPC. This evidence concerns the gene NPC1 and nasopharyngeal carcinoma.